DMD Bio-Rad Microplate Reader

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on July 24, 2008; DOI: 10.1124/dmd.108.021857

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Guo, J.
Right arrow Articles by van Breemen, R. B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guo, J.
Right arrow Articles by van Breemen, R. B.


Received for publication April 15, 2008.
Revised July 22, 2008.
Accepted for publication July 23, 2008.

Biotransformation of the chemopreventive agent isoliquiritigenin by UDP-glucuronosyltransferases

Jian Guo 1, Ang Liu 1, Hongmei Cao 1, Yan Luo 1, John M. Pezzuto 2, Richard B. van Breemen 3*

1 University of Illinois at Chicago 2 University of Hawaii at Hilo 3 University of Ilinois at Chicago

* Address correspondence to: E-mail: breemen{at}uic.edu

Abstract

Isoliquiritigenin (2’,4’,4-trihydroxychalcone), a chalcone found in licorice root and shallots, exhibits antioxidant, estrogenic, and anti-tumor activities. To complement our previous studies concerning the phase 1 metabolism of isoliquiritigenin, the phase 2 transformation of isoliquiritigenin by human hepatocytes and pooled human liver microsomes was investigated using liquid chromatography-tandem mass spectrometry and UV absorbance. Five glucuronides were detected corresponding to monoglucuronides of isoliquiritigenin and liquiritigenin, but no sulfate conjugates were observed. The UDP-glucuronosyltransferases (UGTs) involved in the formation of the major glucuronide conjugates were identified using recombinant human UGTs in combination with LC-MS. UGT1A1 and UGT1A9 were the major enzymes responsible for the formation of the most abundant conjugate, isoliquiritigenin 4'-O-glucuronide (MG5) with Km values of 4.30 ± 0.47 µM and 3.15 ± 0.24 µM, respectively. UGT1A1 and UGT1A10 converted isoliquiritigenin to the next most abundant phase 2 metabolite, isoliquiritigenin 2'-O-glucuronide (MG4) with Km values of 2.98 ± 0.8 µM and 25.8 ± 1.3 µM, respectively. In addition, the isoliquiritigenin glucuronides MG4 and MG5 were formed by pooled human intestine and kidney microsomes, respectively. Based on the in vitro determination of a 25.3 min half-life for isoliquiritigenin when incubated with human liver microsomes, the intrinsic clearance of isoliquiritigenin was estimated to be 36.4 mL/min/kg. These studies indicate that isoliquiritigenin will be conjugated rapidly in the liver to form up to five monoglucuronides.


Key words: glucuronidation, hepatocytes, liver microsomes, metabolite identification, metabolite kinetics, microsomes, UDP glucuronyltransferases





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.